Methylphenidate-induced acute orofacial and extremity dyskinesia

Journal of Child Neurology

Volumn 28, Issue 6, 2013, Pages 778-780

  Yilmaz, Ayse Esra ^a   Donmez, Ahsen ^a   Orun, Emel ^a   Tas, Tugba ^a   Isik, Bunyamin ^a   Sonmez, Fatma Mujgan ^a  

^a FATIH UNIVERSITY   (Turkey)

Author keywords

ADHD; attention deficit hyperactivity disorder; dyskinesia; methylphenidate; orofacial

Indexed keywords

METHYLPHENIDATE; VALPROIC ACID; ANTICONVULSIVE AGENT; CENTRAL STIMULANT AGENT;

ANTERIOR CRANIAL FOSSA; ARACHNOID CYST; ARTICLE; ATTENTION DEFICIT DISORDER; CASE REPORT; CHILD; DISEASE DURATION; DRUG HALF LIFE; DYSKINESIA; ELECTROENCEPHALOGRAPHY; EPILEPSY; FOLLOW UP; HOSPITALIZATION; HUMAN; INCIDENTAL FINDING; LEFT HEMISPHERE; LIMB DYSKINESIA; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; OROFACIAL DYSKINESIA; PRIORITY JOURNAL; SCHOOL CHILD; TEMPORAL LOBE; ATTENTION-DEFICIT/HYPERACTIVITY DISORDER; CHEMICALLY INDUCED DISORDER; DRUG COMBINATION; DRUG INTERACTION; FRONTAL LOBE EPILEPSY; MEIGE SYNDROME; OROFACIAL;

ADHD; ATTENTION-DEFICIT/HYPERACTIVITY DISORDER; DYSKINESIA; METHYLPHENIDATE; OROFACIAL;

ANTICONVULSANTS; ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; CENTRAL NERVOUS SYSTEM STIMULANTS; CHILD; DRUG INTERACTIONS; DRUG THERAPY, COMBINATION; DYSKINESIA, DRUG-INDUCED; EPILEPSY, FRONTAL LOBE; HUMANS; MALE; MEIGE SYNDROME; METHYLPHENIDATE; VALPROIC ACID;

EID: 84878027155     PISSN: 08830738     EISSN: 17088283     Source Type: Journal    
DOI: 10.1177/0883073812449905     Document Type: Article

References (10)

1. Jensen PS, Hinshaw SP, Swansom JM, et al. Findings from the NIMH Multimodal Treatment Study of ADHD (MTA): implications and applications for primary care providers. J Dev Behav Pediatr. 2001 ; 22: 60-73
2. Cry M, Brown CS. Current drug therapy recommendation for the treatment of attention deficit hyperactivity disorder. Drugs. 1998 ; 56: 215-223
3. Efron D, Jarman F, Barker M. Side effects of methylphenidate and dexamphetamine in children with attention deficit hyperactivity disorder: a double-blind, crossover trial. Pediatrics. 1997 ; 100: 662-666
4. Balázs J, Besnyo M, Gádoros J. Methylphenidate-induced orofacial and extremity dyskinesia. J Child Adolesc Psychopharmacol. 2007 ; 17: 378-381
5. Thiel A, Dressler D. Dyskinesias possibly induced by norpseudoephedrine. J Neurol. 1994 ; 241: 167-169
6. Senecky Y, Lobel D, Diamond GW, et al. Isolated orofacial dyskinesia: a methylphenidate-induced movement disorder. Pediatr Neurol. 2002 ; 27: 224-226
7. Case Q, McAndrew JB. Dexedrine dyskinesia: an unusual iatrogenic tic. Clin Pediatr (Phila). 1974 ; 13: 69
8. Mattson RH, Calverley JR. Dextroamphetamine-sulfate-induced dyskinesias. JAMA. 1968 ; 204: 400-402
9. Connor DF. Stimulants and neuroleptic withdrawal dyskinesia. J Am Acad Child Adolesc Psychiatry. 1998 ; 37: 247-248
10. Gara L, Roberts W. Adverse response to methylphenidate in combination with valproic acid. J Child Adolesc Psychopharmacol. 2000 ; 10: 39-43